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Abstract 29	
Antimicrobial photodynamic therapy (aPDT) may be useful as a supportive 30	
antimicrobial measure for caries-active subjects. In this study, the antimicrobial 31	
efficacy of aPDT with a phenalen-1-one photosensitizer is evaluated in a novel in 32	
vitro biofilm model comprising Actinomyces naeslundii, Actinomyces odontolyticus 33	
and Streptococcus mutans and compared to chlorhexidine. The proposed biofilm 34	
model allows high-throughput screening for antimicrobial efficacy while exhibiting a 35	
differentiated response towards different antimicrobial approaches. While 36	
chlorhexidine 0.2% showed reduction of ≈4 log10 for all species, aPDT led to more 37	
pronounced reduction of S. mutans (2.8 log10) than Actinomyces spp. (1.2 or 1.3 38	
log10). A similar effect was also observed in monospecies biofilms. Therefore, aPDT 39	
may be more effective against S. mutans than Actinomyces spp. when in biofilms, 40	
and this antimicrobial approach merits further investigations.  41	
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Introduction 42	
According to the Global Burden of Disease 2015 study, dental caries was still found 43	
to be the most prevalent disease worldwide, affecting about 2.3 billion adults and 560 44	
million children [GBD 2015 Disease and Injury Incidence and Prevalence 45	
Collaborators, 2016] and, accordingly, may be considered as a major economic 46	
burden for public health care [Sheiham, 2001]. With regard to distribution of dental 47	
caries, it is well known that there are several disparities by social standing mostly 48	
because of differences in diet, fluoride use, and social empowerment, resulting in a 49	
sub-population with strong caries incidence [Edelstein, 2006]. Therefore, the 50	
development of prevention concepts for these high-risk patients remains a major 51	
goal. 52	
In this regard, supportive antimicrobial measures may be useful in daily oral hygiene 53	
practice additionally to mechanical removal of biofilms for caries-active patient 54	
subgroups [Cate, 2009]. The widely used antiseptic of choice is chlorhexidine (CHX), 55	
either applied as oral rinse or as gel or varnish [Walsh et al., 2015]. However, its 56	
actual impact on caries prevention is debated controversially and its use exhibits 57	
some undesirable side-effects like yellow-brown staining of teeth and tongue and 58	
altering the sense of taste [Autio-Gold, 2008]. Furthermore, recently its use has been 59	
recommended to be limited to “those applications with a clear patient benefit” (mostly 60	
in intensive care) for reducing the risk of inducing acquired resistances to CHX or 61	
even cross-resistances towards antibiotics in pathogens [Kampf, 2016]. Accordingly, 62	
Kitagawa et al. reported that repeated exposure of Enterococcus faecalis to CHX 63	
resulted in drug resistance as demonstrated by increased minimum inhibitory 64	
concentrations [Kitagawa et al., 2016].  65	
In this instance, the antimicrobial photodynamic therapy (aPDT) may be a promising 66	
alternative [Gursoy et al., 2013; Wainwright et al., 2017]. aPDT is a three-component 67	
system, consisting of a per se non-toxic dye (photosensitizer, PS), light of an 68	
appropriate wavelength and molecular oxygen. When the PS-molecule is activated 69	
by light, it transmits to an excited state, wherefrom there are two mechanisms to 70	
regain its ground state: In type I mechanism, charge is transferred to a substrate or 71	
molecular oxygen resulting in emergence of oxygen radicals like superoxide ions and 72	
hydroxyl radicals or hydrogen peroxide. In type II mechanism, energy is transferred 73	
to molecular oxygen, resulting in generation of singlet oxygen (1O2), which is 74	
regarded as the most effective reactive oxygen species [Wainwright, 1998; Cieplik et 75	
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al., 2014; Wainwright et al., 2017]. Hereby, the singlet oxygen quantum yield FD 76	
describes the proportion of type II mechanism [Maisch et al., 2007]. Due to its 77	
unselective mechanism of action, the potential of resistance induction towards aPDT 78	
is very unlikely [Tavares et al., 2010; Giuliani et al., 2010], especially for type II 79	
mechanism [Cieplik et al., 2013]. Accordingly, PS based on a phenalen-1-one 80	
structure seem to be particularly advantageous due to their high singlet oxygen 81	
quantum yield FD ³ 0.95 [Späth et al., 2014; Cieplik et al., 2013; Tabenski et al., 82	
2016]. Furthermore, for oral application, esthetic compromises for patients will not be 83	
an issue due to the tooth-like color of phenalen-1-one derivatives [Späth et al., 2014]. 84	
However, before any clinical application it is mandatory to evaluate novel 85	
antimicrobial approaches for their efficacy against biofilms as it is well known that 86	
bacteria embedded in biofilms exhibit strongly enhanced tolerance towards 87	
antimicrobials challenges as compared to their planktonic counterparts [Marsh, 88	
2004]. Accordingly, it is of vital importance to develop in vitro biofilm models that are 89	
easy to operate and allow high-throughput screening of given antimicrobial 90	
compounds or approaches. 91	
The aim of the present study was to evaluate the antimicrobial efficacy of phenalen-92	
1-one mediated aPDT on a novel polymicrobial biofilm model cultured from caries-93	
associated bacteria in vitro, in comparison to the gold-standard antiseptic 94	
chlorhexidine. 95	
 96	
 97	
 98	
Materials and Methods 99	
Chemicals and light source 100	
The PS used in this study was 2-((4-pyridinyl)methyl)-1H-phenalen-1-one chloride 101	
and had been synthetized at the Department of Organic Chemistry (University of 102	
Regensburg, Germany), as described earlier in detail (purity ≥ 99%) [Cieplik et al., 103	
2013; Späth et al., 2014]. PS-suspensions were freshly prepared for the experiments 104	
and stored in the dark at 4°C for no longer than 2 weeks. For irradiation of the PS, a 105	
gas-discharge lamp (Waldmann PIB 3000; Waldmann Medizintechnik, Villingen-106	
Schwenningen, Germany) was employed (λem 380–600 nm). Irradiance was adjusted 107	
to 50 mW/cm2 at sample-level, resulting in an energy dose of 30 J/cm2 for an 108	
irradiation period of 10 min. Chlorhexidine-digluconate dissolved in aqua dest. was 109	
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prepared by the pharmacy department of the University Medical Center Regensburg 110	
yielding concentrations of 0.2% and 2%. 111	
 112	
Bacterial culture and biofilm formation 113	
Three reference strains, Actinomyces naeslundii (DSM-43013), Actinomyces 114	
odontolyticus (DSM-19120) and Streptococcus mutans (DSM-20523) were obtained 115	
from DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen, 116	
Braunschweig, Germany) to be used in this study. Bacteria were grown and 117	
maintained on Columbia Agar plates (provided by the Institute for Microbiology and 118	
Hygiene, University Medical Center Regensburg, Germany) in a microincubator 119	
(MI23NK, SCHOLZEN Microbiology Systems, Necker, Switzerland) under anaerobic 120	
conditions (80% N2, 10% CO2, 10% H2). Modified Fluid Universal Medium (mFUM) 121	
supplemented with 67 mmol/l Sørensen’s buffer (pH 7.2) and containing 122	
carbohydrate (0.15% (w/v) glucose and 0.15% (w/v) sucrose) was employed as a 123	
basal liquid medium [Guggenheim et al., 2001; Gmür, and Guggenheim, 1983]. For 124	
preparation of planktonic cultures, colonies were picked and suspended in 5 ml of 125	
mFUM with 0.5 ml fetal bovine serum (FBS; Gibco® life technologies, Carlsbad, CA, 126	
USA) for 24 h under anaerobic conditions to obtain bacteria in the stationary growth 127	
phase. Afterwards, suspensions were harvested by centrifugation (ROTINA 420 R, 128	
Hettich Lab Technology, Tuttlingen, Germany) and resuspended in mFUM yielding 129	
an optical density (OD) of 1.0, as measured by means of a spectrophotometer 130	
(Ultrospec 3300 pro, Amersham Biosciences, Amersham, UK). Bacterial suspensions 131	
were diluted 1:9 in the biofilm culture medium (BCM) consisting of 50% mFUM, 10% 132	
FBS and 40% whole unstimulated human saliva (saliva) that had been pooled from 133	
two volunteers (authors FW, DM) and sterile-filtered (pore size: 0.2 µm; Acrodisc® 134	
Syringe Filters, Pall, Newquaw, UK). 135	
Polyspecies biofilms were formed in 96-well polystyrene culture plates (Corning® 136	
Costar®, Corning, NY, USA). For simulation of pellicle coating, wells were incubated 137	
with saliva for 2 h at room temperature. After that, saliva was discarded, and wells 138	
were filled with 200 μl of BCM containing A. naeslundii and A. odontolyticus and 139	
incubated under anaerobic conditions. After 16 h, medium was carefully removed 140	
and 200 μl fresh BCM containing S. mutans was added. After 48 h, a further medium 141	
change was performed and biofilms were incubated for another 24 h. 142	
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Formation of monospecies biofilms was performed accordingly: after a 2 h incubation 143	
with saliva, wells were filled with 200 μl of BCM containing A. naeslundii, A. 144	
odontolyticus or S. mutans, respectively. Medium changes were after 24 h and 48 h. 145	
In all cases, the total culture period was 72 h. 146	
 147	
Antimicrobial assay 148	
After 72 h, medium was carefully discarded from the wells and the biofilms were 149	
either incubated with phosphate buffered saline	 (PBS; Biochrom, Berlin, Germany; 150	
groups PS-L-, PS-L+) or PS (groups PS+L-, PS+L+), respectively, in the dark for 10 151	
min and then illuminated for another 10 min or incubated with CHX 0.2% or CHX 2% 152	
for a total of 20 min (50 μl each). Immediately afterwards, PBS, PS or CHX was 153	
carefully removed and each biofilm was brought to suspension with 200 μl of PBS 154	
and transferred to an Eppendorf tube. These were placed in an ultrasonic water-bath 155	
chamber (Sonorex Super RK 102 H, Bandelin, Berlin, Germany) obtaining a 156	
frequency of 35 kHz for 10 min and vortexed (REAX top, Heidolph Instruments, 157	
Schwabach, Germany) for 5 s to separate aggregated bacteria. Tenfold serial 158	
dilutions (10-2 to 10-7) were prepared in PBS and aliquots (180 μl) were plated on 159	
Columbia blood agar and incubated anaerobically for 72 h. Afterwards, colony 160	
forming units (CFU) were evaluated. For polyspecies biofilms, bacteria on agar plates 161	
were differentiated by their respective colony morphology. 162	
 163	
Data analysis 164	
All results are shown as medians and neighboring quartiles (25/75% percentiles) and 165	
were calculated using SPSS for Windows, v. 23 (SPSS Inc., Chicago, IL, USA) from 166	
the values of at least six independent experiments, each performed in duplicate. 167	
Horizontal dotted and dashed lines represent reductions of 3 and 5 log10 steps of 168	
CFU, respectively, compared to the matching untreated control group PS-L-. 169	
Medians on or below these lines demonstrate antimicrobial efficacy of at least 99.9% 170	
(3 log10) or 99.999% (5 log10), respectively, which is declared as biologically relevant 171	
antimicrobial activity or disinfectant effect according to the guidelines of infection 172	
control [Boyce, and Pittet, 2002]. 173	
 174	
 175	
 176	
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Results 177	
Antimicrobial efficacy against polyspecies biofilms 178	
Untreated polyspecies biofilms (PS-L-) showed an overgrowth of S. mutans (4.7x107) 179	
of ≈1 log10-step as compared to A. naeslundii (3.8x106) and A. odontolyticus 180	
(4.3x106). The left panel of Figure 1 shows absolute CFU values of untreated 181	
controls while the right panel depicts relative CFU data with untreated controls 182	
(groups PS-L-) set to 100%. 183	
aPDT reduced CFU of S. mutans (2.8 log10) more than CFU of A. naeslundii and A. 184	
odontolyticus (1.2 or 1.3 log10, respectively), while treatment with PS (PS+L-) or light 185	
alone (PS-L+) had no effect. CHX 0.2% reduced CFU of all species by ≈4 log10-steps 186	
(S. mutans: 4.0 log10; A. naeslundii: 4.5 log10; A. odontolyticus: 3.8 log10) while CHX 187	
2% led to eradication by >6 log10 below the detection limit. 188	
 189	
Antimicrobial efficacy against monospecies biofilms 190	
Untreated monospecies biofilms (groups PS-L-) showed growth of 2x108, 4x107 and 191	
1x106 CFU for S. mutans, A. naeslundii and A. odontolyticus, respectively. Figure 2 192	
shows relative CFU data with untreated controls (groups PS-L-) set to 100%. 193	
CFU-reductions for aPDT (PS+L+) were 3.0 log10 for S. mutans, while A. naeslundii 194	
and A. odontolyticus were reduced by 2.5 log10 or 1.1 log10, only. In contrast, CHX 195	
0.2% led to reduction rates of 4.3 log10 for S. mutans and A. odontolyticus, while CFU 196	
of A. naeslundii were reduced by 6.0 log10. Treatment with PS (PS+L-) or light only 197	
(PS-L+) had no effect in all cases. 198	
 199	
 200	
 201	
Discussion 202	
The aim of the present study was to investigate the antimicrobial efficacy of 203	
phenalen-1-one mediated aPDT as compared to the gold-standard antiseptic 204	
chlorhexidine for inactivation of biofilms from cariogenic bacteria in vitro. For this 205	
purpose, a novel biofilm model for high-throughput screening of antimicrobial 206	
approaches was established comprising Actinomyces naeslundii, Actinomyces 207	
odontolyticus and Streptococcus mutans. A. naeslundii is considered to be an 208	
essential early colonizer in dental plaque [Dige et al., 2009], while A. odontolyticus is 209	
suggested to be a key organism mediating adhesion and co-aggregation in 210	
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supragingival plaque [Tang et al., 2003] and is associated with high caries incidence 211	
in children [ElSalhy et al., 2016]. S. mutans is well-known to play a major role in 212	
pathogenesis of dental caries mostly due to its ability to produce an insoluble 213	
polymeric matrix and its acidogenic and aciduric properties [Klein et al., 2015]. 214	
The culture conditions for this biofilm model have been modified from the Zurich 215	
biofilm model of supragingival plaque originally described by Guggenheim and co-216	
workers [Guggenheim et al., 2001]: Instead of pasteurization of human saliva, filter-217	
sterilization was employed because the latter is deemed to be preferable in terms of 218	
protein integrity [Ruhl et al., 2011]. Furthermore, concentrations of carbohydrates in 219	
mFUM were changed from 0.15% glucose towards 0.15% sucrose and 0.15% 220	
glucose each, since S. mutans requires sucrose for glucosyltransferase-mediated 221	
synthesis of exopolysaccharides [Kreth et al., 2008; Koo et al., 2010], while 222	
Actinomyces spp. preferentially utilize glucose for their metabolism via the Embden-223	
Meyerhof-Parnas pathway [Takahashi, and Yamada, 1999]. Proportions of mFUM, 224	
saliva and FBS in the biofilm culture medium were adjusted to 50%, 40% and 10%, 225	
respectively, for increasing biofilm density and sturdiness [Ammann et al., 2012]. In 226	
contrast to the Zurich biofilm model, biofilms were cultured in 96-well plates rather 227	
than on hydroxyapatite discs placed in 24-well plates for ensuring optimal 228	
experimental conditions for antimicrobial evaluation of light-based approaches like 229	
aPDT. Otherwise, biofilms growing on both sides of the hydroxyapatite discs may 230	
have impeded standardized irradiation procedures. Biofilm culture was started with A. 231	
naeslundii and A. odontolyticus, while S. mutans was added after 24 h of culture for 232	
preventing outgrowth of this species with respect to the slower cell division of 233	
Actinomyces spp. relative to streptococci [Dige et al., 2009]. Accordingly, it was 234	
recently shown that, when S. oralis is absent, S. mutans dominates the Zurich biofilm 235	
at the expense of A. oris [Thurnheer, and Belibasakis, 2018]. Furthermore, S. mutans 236	
colonizes in vitro much less efficiently on streptococcal biofilms than on A. naeslundii 237	
biofilms [Wang et al., 2011]. 238	
As compared to the Zurich biofilm model of supragingival plaque and its various 239	
modifications comprising up to 11 bacterial or fungal species [Guggenheim et al., 240	
2001; Ammann et al., 2012; Shapiro et al., 2002; Belibasakis, and Thurnheer, 2014], 241	
this biofilm model is less complex in terms of species diversity, but on the other hand 242	
allows easy and high-throughput screening while still being robust towards 243	
antimicrobial challenge. Treatment with CHX 2.0% for 20 min served as a positive 244	
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control leading to total eradication of biofilm bacteria below detection limit. In 245	
contrast, treatment with CHX 0.2% resulted in a reduction of ≈4 log10 steps while 246	
shorter treatment periods exhibited substantially lower inactivation rates (data not 247	
shown). This is in line with the literature, where Wilson reported no antimicrobial 248	
effect of CHX 0.2% after treating 72 h old S. mutans biofilms for 5 min, but 249	
eradication by >6 log10 below detection limit after treatment for 60 min [Wilson, 1996]. 250	
Likewise, Voos et al. found inactivation of ≈1 log10 after treating biofilms formed in 251	
situ with CHX 0.2% for 3 min [Voos et al., 2014] while Hoogenkamp et al. showed ≈2 252	
log10 inactivation of S. mutans biofilms after treatment for 5 min [Hoogenkamp et al., 253	
2009]. In general, there is a strong and crucial correlation between treatment period 254	
and antimicrobial efficacy especially when it comes to biofilms [Mah, and O'Toole, 255	
2001; Stewart, and Costerton, 2001]. Diffusion of given antimicrobials into deeper 256	
layers of the biofilm may be hampered or slowed by interaction of these positively 257	
charged molecules with the negatively charged residues of the biofilm’s extracellular 258	
polymeric substance (EPS) [Tseng et al., 2013; Thurnheer et al., 2003]. Therefore, 259	
shorter treatment periods may just lead to killing of bacteria in the superficial layers of 260	
the biofilm as it has been shown in the classic study by Zaura et al. [Zaura-Arite et 261	
al., 2001]. 262	
Treatment with aPDT led to less pronounced inactivation rates as compared to CHX. 263	
S. mutans was inactivated by 2.8 log10 while A. naeslundii and A. odontolyticus 264	
exhibited killing rates of 1.2 or 1.3 log10 only. It is noteworthy to say that despite 265	
identical total treatment period of 20 min (10 min of incubation in the dark followed by 266	
10 min of irradiation), the period of antimicrobial activity of aPDT is limited to the time 267	
when the light is switched on. Interestingly, although aPDT is known to be an 268	
unselective antimicrobial approach [Wainwright et al., 2017], S. mutans exhibited 269	
noticeably higher susceptibility towards phenalene-1-one mediated aPDT as 270	
compared to both, A. naeslundii and A. odontolyticus. The influence of subsequent 271	
addition of S. mutans, potentially leading to only superficial colonization of this 272	
species within the biofilm, can be ruled out because in this instance S. mutans would 273	
have been inactivated more severely than both Actinomyces spp. in the CHX groups, 274	
too. The higher susceptibility of S. mutans towards aPDT was further substantiated 275	
by investigating antimicrobial efficacy towards monospecies biofilms of all three 276	
species. Likewise, aPDT showed higher inactivation efficacy in S. mutans biofilms 277	
(3.0 log10) as compared to A. naeslundii (2.5 log10) and A. odontolyticus biofilms (1.1 278	
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log10). These results are in contrast to a previous study where aPDT with the same 279	
PS as used in the present study resulted in a 6.5 log10 inactivation against A. 280	
naeslundii monospecies biofilms [Cieplik et al., 2015]. However, this difference in 281	
antimicrobial efficacy may be due to employing a distinct strain (A. naeslundii T14V) 282	
and due to the longer incubation period (25 min) [Cieplik et al., 2015], again 283	
elucidating the crucial impact of treatment period. 284	
Actinomyces spp. are generally known for their thick and robust cell walls, which are 285	
resistant to salivary lysozyme and other peptidoglycan-hydrolyzing enzymes [Delisle 286	
et al., 2006] Therefore, the higher tolerance towards aPDT may be due to an 287	
insufficient permeability for PS molecules through the cell membrane, as suggested 288	
by Dige et al. as cause for the irregular distribution of fluorescent signals when 289	
applying FISH to A. naeslundii [Dige et al., 2009]. Furthermore, Actinomyces spp. 290	
tend to cluster together [Dige et al., 2009] and may even be encapsulated by 291	
streptococci as it has been proposed by Bos et al. [Bos et al., 1996]. 292	
To the best of our knowledge, there are no other reports in the literature on the 293	
effects of aPDT on polymicrobial biofilms formed in vitro from caries-associated 294	
species, such as S. mutans and Actinomyces spp. Therefore, the higher tolerance of 295	
Actinomyces spp. towards phenalen-1-one mediated aPDT found here may justify 296	
more detailed investigation in future studies, e.g. by using flow cytometry for 297	
investigation of membrane alterations. This phenomenon merits further investigation 298	
as it may be utilized clinically by repeated application of aPDT to induce a shift from 299	
highly cariogenic streptococci-dominated to less cariogenic Actinomyces-dominated 300	
microbiota in caries-active patients, which may be an interesting approach for biofilm-301	
modulation in view of the ecological plaque hypothesis [Marsh et al., 2015]. 302	
However, before any clinical application of phenalen-1-one mediated aPDT potential 303	
harmful effects on mammalian tissues must be ruled out. As a first step, in a recent 304	
study aPDT with several phenalen-1-one derivatives was investigated for its 305	
antimicrobial efficacy towards planktonic cultures of dermal pathogens and for its 306	
eukaryotic toxicity towards keratinocytes as compared to the biocide benzalkonium 307	
chloride (BAC) in order to evaluate a potential effective concentration range (i.e. ≥5 308	
log10 steps reduction of CFU while ≥80% survival of keratinocytes) [Muehler et al., 309	
2017]. For the PS used in the present study, no harmful effects were found in the 310	
dark. In combination with light there was a broad effective concentration range, while 311	
for BAC no effective concentration range could be found at all [Muehler et al., 2017]. 312	
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Although these results are encouraging, further biocompatibility studies will be 313	
necessary to establish the clinical safety of phenalen-1-one mediated aPDT. 314	
 315	
 316	
 317	
Conclusion 318	
In this study, a novel caries biofilm model is described comprising A. naeslundii, A. 319	
odontolyticus and S. mutans, which allows easy and high-throughput screening of 320	
given compounds or approaches while exhibiting sturdiness towards antimicrobial 321	
challenges. While treatment with CHX 0.2% inactivated all species by of ≈4 log10 322	
steps, phenalen-1-one mediated aPDT led to more pronounced inactivation of S. 323	
mutans (2.8 log10) as compared to A. naeslundii (1.2 log10) and A. odontolyticus (1.3 324	
log10) which was similarly found in monospecies biofilms. 325	
 326	
 327	
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Figure Legends 466	
 467	
Figure 1: Antimicrobial efficacy on polyspecies biofilms. 468	
All results are shown as medians and neighboring quartiles depicted on a log10-469	
scaled ordinate. 470	
Left panel shows absolute CFU data of untreated control groups (PS-L-) exhibiting 471	
over-growth of S. mutans of ≈1 log10 as compared to both Actinomyces spp. 472	
Right panel depicts relative CFU data with untreated controls (groups PS-L-) set to 473	
100%. Horizontal dotted and dashed lines represent CFU-reductions of 3 log10 and 5 474	
log10, respectively, as compared to untreated control groups (PS-L-). There was no 475	
effect of light (PS-L+) or PS alone (PS+L-). aPDT (PS+L+) led to higher CFU-476	
reduction of S. mutans (2.8 log10) than of A. naeslundii (1.2 log10) and A. 477	
odontolyticus (1.3 log10). CHX 0.2% reduced CFU of S. mutans by 4.0 log10, A. 478	
naeslundii by 4.5 log10 and A. odontolyticus by 3.8 log10. CHX 2% led to reduction of 479	
CFU by >6 log10 below detection limit. 480	
 481	
Figure 2: Antimicrobial efficacy on monospecies biofilms. 482	
All results are shown as medians and neighboring quartiles depicted on a log10-483	
scaled ordinate as relative CFU data with the respective untreated controls (groups 484	
PS-L-) set to 100%. Horizontal dotted and dashed lines represent CFU-reductions of 485	
3 log10 and 5 log10, respectively, as compared to the respective untreated control 486	
groups (PS-L-). 487	
There was no effect of light (PS-L+) or PS alone (PS+L-). aPDT (PS+L+) led to CFU-488	
reductions of 3.0 log10 for S. mutans biofilms, while CFU in A. naeslundii and A. 489	
odontolyticus biofilms were reduced by 2.5 log10 or 1.1 log10, respectively. CHX 0.2% 490	
reduced CFU in S. mutans and A. odontolyticus biofilms by 4.3 log10 and in A. 491	
naeslundii biofilms by 6.0 log10. 492	


